A. Raviele

Cardiac Arrhythmias 1997 (eBook, PDF)

• Format: PDF

Produktbeschreibung

The book comprises the proceedings of the 5th International Workshop on Cardiac arrhythmias, held in Venice, October 7-10,1997 and represents an update on the most recent advances in the diagnosis, prognosis and treatment of cardiac arrhythmias.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer Milan
• Seitenzahl: 562
• Erscheinungstermin: 11. November 2013
• Englisch
• ISBN-13: 9788847022881
• Artikelnr.: 44180640

Autorenporträt

The book comprises the proceedings of the 5th International Workshop on Cardiac arrhythmias, held in Venice, October 7-10,1997 and represents an update on the most recent advances in the diagnosis, prognosis and treatment of cardiac arrhythmias.

Inhaltsangabe

Atrial Fibrillation: Mechanisms and Clinical Aspects.- What Are the Electrophysiological Mechanisms of Perpetuation of Atrial Fibrillation?.- Vagal Tone: How Important Is It in Triggering Atrial Fibrillation?.- Tachycardia Induced Atrial Fibrillation: What Incidence? How to Diagnose and Treat It?.- Atrial Fibrillation: Cardioversion and Drug Prophylaxis.- Restoration of Sinus Rhythm: Pharmacological or Electrical?.- Atrial Fibrillation: Which Drug to Prefer for Acute Cardioversion?.- Drug Prevention of Paroxysmal Atrial Fibrillation, When and How?.- Antiarrhythmic Drug Administration before Electrical Cardioversion of Atrial Fibrillation: Is It Useful to Prevent Early Arrhythmia Recurrence?.- Atrial Fibrillation: Ablation Procedures.- AV-Nodal Ablation versus AV-Nodal Modification for Control of Atrial Fibrillation.- AV Junction Modification for Atrial Fibrillation: Which End Points?.- Heart Failure Patients with Atrial Fibrillation: How Important Is It to Regularize Ventricular Rhythm?.- Catheter Ablation of Atrial Fibrillation: Where Are We Now and Where Are We Going?.- Atrial Fibrillation: Internal Defibrillation.- Restricted or Expanded Indications for Low-Energy Internal Cardioversion?.- Internal Atrial Defibrillation: What Are the Effects on Mechanical Function?.- Implantable Atrial Defibrillator: Which Results and Indications?.- The Implantable Atrial Defibrillator: Are All the Problems Solved.- Atrial Fibrillation: Prevention of Thromboembolism.- Atrial Fibrillation and Thromboembolic Risk: Is It Safe to Cardiovert Acutely under Heparin?.- Prevention of Thromboembolism in Atrial Fibrillation: When Antiplatelet Agents and When Anticoagulants?.- Atrial Flutter and Other Supraventricular Tachyarrhythmias.- Inappropriate Sinus Tachycardia: Mechanism and Therapy.- What Is the Relationship between Atrial Fibrillation and Flutter in Man?.- Physiology of AV Junction: What Have We Learnt from Radiofrequency Ablation?.- What Is the Clinical Significance of Ventricular Repolarization Abnormalities during Supraventricular Tachyarrhythmias?.- Prolonged or Failed Attempts at RF Ablation of Accessory Pathways: What Are the Causes?.- Sudden Death Risk Stratification after Acute Myocardial Infarction.- What Is the Clinical and Prognostic Significance of Atrioventricular and Intraventricular Conduction Defects?.- What Is the Usefulness of Ventricular Premature Beats and Ventricular Late Potentials in the Thrombolytic Era?.- What Is the Predictive Value of Heart Rate Variability and Baroreflex Sensitivity?.- Clinical Usefulness of QT Prolongation, QT Dispersion and T-Wave Alternans.- Risk Stratification after Acute Myocardial Infarction: What Is the Usefulness of Programmed Ventricular Stimulation?.- Prevention of Sudden Death in Post-MI Patients.- After CAMIAT and EMIAT What is the Role for Amiodarone in the Prevention of Sudden Death.- Beta-blockers Prevent Sudden Death: so Why Is Their Use Limited after Myocardial Infarction?.- Prevention of Sudden Death in Post-MI Patients: What Is the Role of Non-Antiarrhythmic Drugs?.- How to Treat High-Risk Post Myocardial Infarction Patients Based on MADIT and Other Recent Trials.- Implantable Cardioverter Defibrillator: Clinical Issues and New Indications.- Which Patients with ICD May Really Benefit from DDD Pacing, and Which Won't?.- Can Alternative Pacing Therapy Solve the Problem of Heart Failure Death in ICD Patients?.- Have MADIT and Recent Post Myocardial Infarction Amiodarone Studies Changed the Classical Indications for ICD Implantation?.- What Have We Learned from the US Experience on the Prophylactic Use of ICDs Following MADIT?.- Risk Stratification of Post-MI Patients. What Are the Limitations of MADIT? What Does the Future Hold in Store?.- Ventricular Tachyarrhythmias: Uncommon Forms.- Idiopathic Left Ventricular Tachycardia: What Is New in Pathophysiology? When and How to Perform RF Ablation?.- Idiopathic Right Ventricular Outflow Tract Tachycardia: Which Substrate, Mechanism and Therapy?.- Long QT Syndrome: from Molecular Biology to Clinical Management.- Arrhythmogenic Right Ventricular Cardiomyopathy: Which Role for Apoptosis?.- How to Diagnose and Manage Right Ventricular Cardiomyopathy Today.- "Brugada Syndrome": A Structural Cardiomyopathy or a Functional Electrical Disease?.- Ventricular Tachyarrhythmias: Management.- Management of Ventricular Tachyarrhythmias: Is Correction of Ischemia Sufficient?.- Appropriate Indications for the Implantable Defibrillator.- The ICD Cannot Impact Non-Arrhythmic Mortality. Or Can It?.- How to Select Patients for ICD Implantation.- Syncope: Advances in Pathophysiology and Diagnosis.- Adenosine-Induced Paroxysmal Atrioventricular Block: a New Possible Cause of Unexplained Syncope?.- Carotid Sinus Syndrome: What Is the Clinical Relevance of the Vasodepressor Component and How to Manage It?.- Current Insight on the Pathophysiology of Vasovagal Syncope: What Have We Learned?.- What Is the Role of Neurohumoral Agents in the Genesis of Vasovagal Syncope?.- Vasovagal Syncope: To Tilt or Not to Tilt?.- Syncope: How Should It Be Evaluated Today?.- Vasovagal Syncope: Therapy.- Is Tilt Testing Really Useful for Selecting Vasovagal Therapy?.- Neurocardiogenic Syncope: What Role for Serotonin?.- Development of an Implantable Drug Delivery System for the Treatment of Vasovagal Syncope: a Dream or a Real Prospect?.- Sensor for Early Recognition of Imminent Vasovagal Syncope.- Is Echocardiographic Investigation Useful for Establishing the Chronological Sequence of Events in Tilt Induced Syncope?.- Cardiac Pacing: New and Controversial Indications.- Pacing from Unconventional Sites: Who, When and Why?.- Hypertrophic Obstructive Cardiomyopathy: Is DDD Pacing Really Useful?.- Is There a Role for Left Ventricular Pacing in the Treatment of Congestive Heart Failure?.- Mobitz Type I and First Degree AV Block: When to Permanently Pace?.- Cardiac Pacing: Different Modes of Stimulation.- Chronotropic Incompetence: How to Diagnose and Treat It?.- New Sensors for Pacing and Diagnostic Application: What Is Their Clinical Uselfulness?.- Single Lead DDD Stimulation: Is It a Real Progress?.- What Is the Real Usefulness of the AutoCapture Function?.- Cardiac Pacing: Other Issues.- Pacemaker and ICD Infections: How to Manage Them?.- Cellular Phones and Pacemakers: How Do They Interact?.- Progress in Non-Pharmacological Treatment of Cardiac Arrhythmias.- Which Patients with Dilated Cardiomyopathy May Really Benefit from Dual-chamber Pacing?.- Atrial Flutter Ablation: Long-Term Results with Standard Approach after Eight Years of Experience.- Is the Evaluation of Heart Rate Variability Before ICD Discharge Useful to Understand the Mechanisms of Sudden Cardiac Death?.- Is QRS Duration a Reliable Parameter in Discriminating between Supraventricular and Ventricular Arrhythmias?.- Which Patients Are Good Candidates for Ventricular Tachycardia Ablation Today?.